Farmantra is invited by Smile...

14th February 2019 In this workshop, we will explore how a good early stage valuation is actually a mix of building right narratives backed by numbers. We will also bust a few...

Farmantra thanks all the...

30th November 2018 Panelists GuillemLaporta – Principal, Ysios Capital, Spain Esteban Pombo-Villar – CEO, Targimmune, Switzerland Christofer Adding – COO,...

Panel discussion on...

29th November 2018 In the pursuit of enhancing value to the Biotech community, Farmantra brought together the Biotech companies and the investors through a panel discussion...

LABIOTECH.eu published...

LABIOTECH.eu published ‘Going Public: A Guide for European Biotechs’ which leveraged Farmantra’s expertise on exit strategies and IPO through Nasdaq vs Euronext. Read More

Farmantra organized a

25th October 2018 Farmantra organized a workshop ‘Early stage valuation: Narratives and Numbers’ in association with Danish Biotech association where Saurabh Mishra discussed:...

Breakfast session organized...

Another interesting ‘Valuation’ session for Farmantra at Karolinska institute where Saurabh Mishra, Managing partner, Farmantra S.L delivered valuable information to the...

Health startups invited...

14th March 2018 Aleap, Norway’s largest community for health startups invited Farmantra to give a talk on early stage valuation and the challenges faced by young Biotechs where...

VC vs Entrepreneurs’...

19th October 2017 LABIOTECH.eu published ‘Negotiating early stage Biotech valuation: VC vs Entrepreneurs’ authored by Saurabh Mishra, Managing Partner, Farmantra. Read More

Load More All Post Loaded